VANGUARD GROUP INC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Cytokinetics Inc (CYTK)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Cytokinetics Inc Common Stock
Symbol: CYTK
Shares outstanding: 118M shares
Disclosed Ownership: 11.9M shares
Ownership: 10.1%
Form type: SCHEDULE 13G/A
Date filed: 1/8/2025, 11:29 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	10.09%	11.9M	0	87.3K	Ashley Grim	Head of Global Fund Administration